Further pharmacological study on Sho-seiryu-to as an antiallergic

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 10, 1997, Pages 707-713

  Sakaguchi, M ^a   Mase, A ^a   Iizuka, A ^a   Yuzurihara, M ^a   Ishige, A ^a   Amagaya, S ^a   Komatsu, Y ^a   Takeda, H ^b   Matsumiya, T ^b  

^a TSUMURA AND CO   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Antiallergic; Histamine H1 receptors; Sho seiryu to

Indexed keywords

ANTIALLERGIC AGENT; HISTAMINE; HISTAMINE H1 RECEPTOR; KAMPO; KETOTIFEN; LEUKOTRIENE C4; LEUKOTRIENE D4; MEPYRAMINE; PILOCARPINE; SEROTONIN; SHO SEIRYU TO; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CONVULSION; GUINEA PIG; HISTAMINE RELEASE; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERITONEUM MAST CELL; RAT; RECEPTOR BINDING; SALIVATION; SKIN MANIFESTATION;

ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; DRUGS, CHINESE HERBAL; GUINEA PIGS; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; LUNG; MALE; MAST CELLS; MICE; PERITONEAL CAVITY; PILOCARPINE; PYRILAMINE; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, HISTAMINE H1; SALIVATION; SKIN TESTS; TRITIUM;

EID: 0031423906     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Baba, S., Kohsaka, T., Inamura, N. et al. Double-blind clinical trial of Sho-seiryu-to (TJ-19) for perennial nasal allergy. Pract Otol Kyoto 1995, 88: 389-405 (in Japanese).
2. Egashira, Y., Yoshida, M., Nagano, H. Clinical evaluation of the Chinese herbal extracts (Sho-seiryu-to) in treatment of bronchial asthma - Results of a multicenter clinical study based on evaluation methods for western drugs. Jpn J Orient Med 1995, 45: 859-76 (in Japanese).
3. Umesato, Y., Iikura, Y., Nakamura, Y. Asthmatic children and Chinese medicine. Scientific study of Sho-seiryu-to and Saibokuto. Jpn J Allergol 1984, 33: 1047-52 (in Japanese).
4. Takeuchi, Y., Nishimura, Y., Yoshikawa, T. et al. A comparison between Chinese blended medicine "shoseiryuto", tranilast and ketotifen on the anti-allergic action in the guinea pigs. Jpn J Allergol 1985, 34: 387-92 (in Japanese).
5. Matsumoto, T., Ishida, M., Hatta, T. et al. Inhibitory effect of Sho-seiryu-to on histamine release and degranulation from rat mast cells. ORL Tokyo 1991, 34: 289-93 (in Japanese).
6. 1 receptors and muscarinic cholinergic system in the brain. Meth Find Exp Clin Pharmacol 1996, 18: 41-7.
7. Ikeda, K., Takasaka, T., Da-Zhen, W. et al. Inhibitory effects of Sho-seiryu-to on acetylcholine-induced responses in nasal gland acinar cells. Am J Chinese Med 1994, 22: 191-6.
8. Umesato, Y., Iikura, Y., Nagakura, T. Asthmatic children and Chinese medicine. I. Effect of "Shoseiryuto" on asthmatic children and guinea pig tracheal smooth muscle. Jpn J Allergol 1982, 31: 297-303 (in Japanese).
9. 1 antagonist, confirmed by the use of d-chlorpheniramine with monitoring electroence-phalography. Meth Find Exp Clin Pharmacol 1993, 15: 183-8.
10. 1-antagonists on electrically-induced seizure in developing mice. Psychopharmacology 1993, 112: 199-203.
11. Abe, T., Omata, T., Yoshida, K. et al. Antiallergic effects of ZCR-2060: Effect on allergic cutaneous reactions and rhinitis models in mice and rats. Jpn J Pharmacol 1994, 66: 95-103.
12. Shore, P.A., Burkhalter, A., Cohn, V.H. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 1959, 127: 182-6.
13. Inagaki, N., Miura, T., Daikoku, M., Nagai, H., Koda, A. Inhibitory effects of β-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators, and mediator releasers in rats. Pharmacology 1989, 39: 19-27.
14. 3H]mepyramine binding of brain membranes. J Neurochem 1979, 32: 1653-63.
15. 3H]mepyramine. Proc Natl Acad Sc USA 1978, 75: 6290-4.
16. Murai, S., Saito, H., Masuda, Y. et al. A modified methodfor quantitative measurements of cholinergic and adrenergic sialogogue-induced salivation in mice. Meth Find Exp Clin Pharmacol 1995, 17: 601-8.
17. Chand, N., Harrison, J.E., Rooney, S.M., Sofia, R.D., Diamantis, W. Inhibition of passive cutaneous anaphylaxis (PCA) by azelastine: Dissociation of its antiallergic activities from antihistaminic and antiserotonin properties. Int J Immunopharmacol 1985, 17: 833-8.
18. Shirasaki, H., Asakura, K. Effect of platelet-activating factor on nasal vascular permeability and eosinophil accumulation in guinea pigs. J Otolaryngol Jap 1990, 93: 615-21 (in Japanese).
19. Lellouch-tubiana, A., Lefort, J., Simon, M-T. et al. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Am Rev Respir Dis 1988, 137: 615-21.
20. Kroegel, C., Yukawa, T., Dent, G. et al. Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol 1989, 142: 3518-26.
21. Yukawa, T., Kroegel, P., Evans, T. et al. Density heterogeneity of eosinophil leucocytes: Induction of hypodense eosinophils by platelet-activating factor. Immunology 1989, 68: 140-3.
22. Narita, S., Asakura, K. The effects of anti-PAF and other agents on the nasal symptoms in sensitized guinea pigs. Auris Nasus Larynx 1993, 20: 175-83.
23. 4 in allergic rhinitis. Ann Allergy 1988, 60: 537-40.
24. Richelson, E. Tricyclic antidepressants: Interactions with histamine and muscarinic acetylcholine receptors. In: Antidepressants: Neurochemical, Behavioral, and Clinical Perspectives. Enna, S.J., Malick, J.B., Richelson, E. (Eds.). Raven Press: New York 1981, 53-73.
25. Onodera, K., Yamatodani, A., Watanabe, T., Wada, H. Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog Neurobiol 1994, 42: 685-702.
26. Churchill, J.A., Gamonn, G.D. The effect of antihistaminic drugs on convulsive seizures. J Am Med Assoc 1949, 141: 18-21.
27. Wyngaarden, J.B., Seevers, M.H. The toxic effects antihistaminic drugs. J Am Med Assoc 1951, 145: 277-83.
28. Grant, S.M., Goa, K.L., Fitton, A., Sorkin, E.M, Ketotifen: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs 1990, 40: 412-48.
29. Kasahara, Y., Hikino, H., Tsurufuji, S., Watanabe, M., Ohuchi, K. Antiinflammatory actions of ephedrines in acute inflammations. Planta Med 1985, 4: 325-331.
30. Iwakami, S., Shibuya, M., Tseng, C.F., Hanaoka, F., Sankawa, U. Inhibition of arachidonate 5-lipoxygenase by phenolic compounds. Chem Pharm Bull 1986, 34: 3960-3.
31. Yamahara, J., Yamada, T., Kimura, H., Sawada, T., Fujimura, H. Biologically active principles of crude drugs. II. Anti-allergic principles in "Shoseiryu-to" anti-inflammatory properties of paeniflorin and its derivatives. J Pharm Dyn 1982, 5: 921-9.
32. Amagaya, S., Sugishita, E., Ogihara, Y et al. Comparative studies of the stereoisomers of glycyrrhetinic acid on anti-inflammatory activities. J Pharm Dyn 1984, 7: 923-9.
33. Nagai, H., Shimazawa, T., Matsuura, N., Koda, A. Immuno-pharmacological studies of the aqueous extract of Cinnamomum Cassia (CCAq) I. Antiallergic action. Jpn J Pharmacol 1982, 32: 813-22.